Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02806427 · ClinicalTrials.gov registry record
Tolerance of a Calorically Dense Enteral Nutrition Formula
A clinical trial of Enteral Feeding, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- 29
- Enrollment target
- 1
- Study location
NCT02806427: Completed study of Enteral Feeding, sponsored by Société des Produits Nestlé (SPN).
NCT02806427 is a study of Enteral Feeding that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 29 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02806427, a study of Enteral Feeding, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- 29 participants
- Enrollment target
- 1
- Study location
Study Summary
This prospective observational study seeks to demonstrate the ability to meet nutritional needs of a calorically dense enteral formula in critically ill patients.
Conditions Studied
Interventions
- OTHER Enteral Formula
Study Locations (1)
Oklahoma
- OUHSC - Oklahoma City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2016-06-30 |
| Est. Completion | 2017-03-11 |
What the finished NCT02806427 record still lists
NCT02806427 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 29 participants, a relatively small participant target.
The record links to 1 condition, with Enteral Feeding appearing as the primary indexed condition, and to 1 intervention - of which Enteral Formula is the first listed.
NCT02806427 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT02806427 about?
NCT02806427 is a clinical study titled "Tolerance of a Calorically Dense Enteral Nutrition Formula". This prospective observational study seeks to demonstrate the ability to meet nutritional needs of a calorically dense enteral formula in critically ill patients.
What is the current status of trial NCT02806427?
This trial is currently completed. The enrollment target is 29 participants. The study started on 2016-06-30. Estimated completion is 2017-03-11.
What conditions does trial NCT02806427 study?
This clinical trial studies the following conditions: Enteral Feeding.
What interventions are being tested in trial NCT02806427?
The interventions under investigation include: Enteral Formula (OTHER).
Who is sponsoring clinical trial NCT02806427?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02806427 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Enteral Feeding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02429557 · 29 participants · Phase 1
Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure
- NCT02568878 · 29 participants · Phase 3
Creatine for Depressed Male and Female Methamphetamine Users
- NCT03014401 · 29 participants · NA
The Effect of Adipose-Derived Stem Cells for Knee Osteoarthritis
- NCT03128996 · 29 participants · Phase 1
Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI